Jenny Han

597 total citations
21 papers, 352 citations indexed

About

Jenny Han is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Jenny Han has authored 21 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Neurology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jenny Han's work include Neurofibromatosis and Schwannoma Cases (5 papers), Signaling Pathways in Disease (4 papers) and Cancer Mechanisms and Therapy (3 papers). Jenny Han is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (5 papers), Signaling Pathways in Disease (4 papers) and Cancer Mechanisms and Therapy (3 papers). Jenny Han collaborates with scholars based in United States, Türkiye and Austria. Jenny Han's co-authors include Haydar Çelik, Aykut Üren, Jeffrey A. Toretsky, Tsion Z. Minas, Daniel E. Frigo, Yan Shi, Yasemin Saygıdeğer, Fatima A. Merchant, Jayantha B. Tennakoon and Alan R. Burns and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Jenny Han

18 papers receiving 346 citations

Peers

Countries citing papers authored by Jenny Han

Since Specialization

Citations

This map shows the geographic impact of Jenny Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Han more than expected).

Fields of papers citing papers by Jenny Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Han. The network helps show where Jenny Han may publish in the future.

Co-authorship network of co-authors of Jenny Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Han. A scholar is included among the top collaborators of Jenny Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Han. Jenny Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 4157: Combining hyperpolarized magnetic resonance and positron emission tomography to interrogate prostate cancer metabolism 2024 ·Cancer Research ·(unknown), (unknown), Prasanta Dutta, Jenny Han, Peter D.A. Shepherd, Daniel E. Frigo, Federica Pisaneschi, Pratip K. Bhattacharya	1
2	Correction: YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model 2024 ·Oncotarget ·Tsion Z. Minas, Jenny Han, Tahereh Javaheri, (unknown), Michaela Schlederer, Yasemin Saygıdeğer, Haydar Çelik, Kristina M. Mueller, (unknown), Metin Özdemirli, Heinrich Kovar, Hayriye V. Erkizan, Jeffrey A. Toretsky, Lukas Kenner, Richard Moriggl, Aykut Üren	0
3	Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris 2023 ·Journal of Drugs in Dermatology ·Lawrence F. Eichenfield, Linda Stein Gold, Jenny Han, Adelaide A. Hebert, (unknown), Luigi Moro, (unknown), Diane Thiboutot	1
4	Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris 2023 ·Journal of Drugs in Dermatology ·Adelaide A. Hebert, Lawrence F. Eichenfield, Diane Thiboutot, Linda Stein Gold, Snejina Vassileva, (unknown), Martina Cartwright, Luigi Moro, (unknown), Jenny Han, (unknown), (unknown)	3
5	Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris 2023 ·Journal of Drugs in Dermatology ·Lawrence F. Eichenfield, Adelaide A. Hebert, Linda Stein Gold, Martina Cartwright, Luigi Moro, Jenny Han, (unknown), (unknown)	2
6	Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer 2022 ·Cells ·(unknown), (unknown), Jenny Han, (unknown), Jeffrey J. Ackroyd, (unknown), Jonathan S. Oakhill, John W. Scott, Michael Ittmann, Daniel E. Frigo	7
7	Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling 2021 ·Oncogene ·Chenchu Lin, Alicia M. Blessing, (unknown), Yan Shi, (unknown), Jenny Han, (unknown), (unknown), (unknown), Sonja N. Brun, Reuben J. Shaw, Michael Ittmann, Daniel E. Frigo	39
8	A simple quantitative PCR assay to determine TRAMP transgene zygosity 2020 ·Prostate Cancer and Prostatic Diseases ·Ruidong Chen, Xin Liang, (unknown), Ellen Karasik, Jenny Han, Ming Zhu, Barbara A. Foster, Daniel E. Frigo, Guocan Wang	1
9	Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99 2018 ·Oncogene ·Haydar Çelik, Marika Sciandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Han, (unknown), Purushottam B. Tiwari, Mutlu Hayran, Brent T. Harris, Maria Cristina Manara, Jeffrey A. Toretsky, Katia Scotlandi, Aykut Üren	25
10	Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma 2017 ·Cancer Research ·Haydar Çelik, Marika Sciandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Han, (unknown), Purushottam B. Tiwari, Mutlu Hayran, Maria Cristina Manara, Jeffrey A. Toretsky, Katia Scotlandi, Aykut Üren	1
11	Ezrin Inhibition Up-regulates Stress Response Gene Expression 2016 ·Journal of Biological Chemistry ·Haydar Çelik, Gülay Bulut, Jenny Han, Garrett T. Graham, Tsion Z. Minas, (unknown), (unknown), Gary T. Pauly, Mutlu Hayran, Xin Li, Metin Özdemirli, A. Ayhan, Michelle A. Rudek, Jeffrey A. Toretsky, Aykut Üren	43
12	Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non–Small Cell Lung Cancer Cells 2016 ·Neoplasia ·Yasemin Saygıdeğer, Tsion Z. Minas, (unknown), (unknown), Haydar Çelik, (unknown), Jenny Han, Neşe Atabey, Hayriye V. Erkizan, Jeffrey A. Toretsky, Aykut Üren	31
13	Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box 2015 ·Molecular Cancer Therapeutics ·Haydar Çelik, (unknown), Daisy D. Colón-López, Jenny Han, Yasemin Saygıdeğer, Tsion Z. Minas, Matthew Swift, Mikell Paige, Eric Glasgow, Jeffrey A. Toretsky, Jürgen Bosch, Aykut Üren	17
14	YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model 2015 ·Oncotarget ·Tsion Z. Minas, Jenny Han, Tahereh Javaheri, (unknown), Michaela Schlederer, Yasemin Saygıdeğer, Haydar Çelik, Kristina M. Mueller, (unknown), Metin Özdemirli, Heinrich Kovar, Hayriye V. Erkizan, Jeffrey A. Toretsky, Lukas Kenner, Richard Moriggl, Aykut Üren	19
15	Abstract 54: Ezrin enhances signaling and nuclear translocation of the epidermal growth factor receptor in non-small cell lung cancer cells 2015 ·Cancer Research ·Yasemin Saygıdeğer, Haydar Çelik, Hayriye V. Erkizan, Tsion Z. Minas, Jenny Han, Jeffrey A. Toretsky, Aykut Üren	0
16	Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level 2015 ·Molecular and Cellular Biology ·Haydar Çelik, Kamal P. Sajwan, Saravana P. Selvanathan, (unknown), (unknown), Yasemin Saygıdeğer, Jenny Han, Tsion Z. Minas, Said Rahim, Hayriye V. Erkizan, Jeffrey A. Toretsky, Aykut Üren	30
17	A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model 2014 ·PLoS ONE ·Said Rahim, Tsion Z. Minas, (unknown), (unknown), Haydar Çelik, Yasemin Saygıdeğer, Jenny Han, Abraham T. Kallarakal, Yali Kong, Michelle A. Rudek, Milton L. Brown, Bhaskar Kallakury, Jeffrey A. Toretsky, Aykut Üren	43
18	Abstract 2450: CaMKK2-AMPK signaling facilitates androgen-mediated prostate cancer cell metabolism 2014 ·Cancer Research ·Daniel E. Frigo, Yan Shi, Jenny Han, Efrosini Tsouko, Michael Ittmann	1
19	To All the Boys I've Loved Before 2014 ·Jenny Han	5
20	University of Central Florida at TRECVID 2007 Semantic Video Classification and Automatic Search. 2007 ·Journal of International Crisis and Risk Communication Research ·Jingen Liu, Yusuf Aytar, (unknown), Jenny Han, Mubarak Shah	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact